Citations for
1CTCFL
BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells.
Janssen SM, Moscona R, Elchebly M, Papadakis AI, Redpath M, Wang H, Rubin E, van Kempen LC, Spatz A.
Cell Death Discov 6:1. doi: 10.1038/s41420-019-0235-x. eCollection 2020. 2020
2CTCF, CTCFL, MAGEA1
MAGEA1 inhibits the expression of BORIS via increased promoter methylation.
Zhao J, Wang Y, Liang Q, Xu Y, Sang J.
J Cell Sci 132(1). pii: jcs218628. doi: 10.1242/jcs.218628. 2019
3CTCFL
Genome-wide bioinformatics analysis reveals CTCFL is upregulated in high-grade epithelial ovarian cancer.
Gong M, Yan C, Jiang Y, Meng H, Feng M, Cheng W.
Oncol Lett 18(4):4030-4039. doi: 10.3892/ol.2019.10736. Epub 2019 Aug 8. 2019
4CTCFL
The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer.
Salgado-Albarrán M, González-Barrios R, Guerra-Calderas L, Alcaraz N, Estefanía Sánchez-Correa T, Castro-Hernández C, Sánchez-Pérez Y, Aréchaga-Ocampo E, García-Carrancá A, Cantú de León D, Herrera LA, Baumbach J, Soto-Reyes E.
Oncogenesis 8(8):41. doi: 10.1038/s41389-019-0150-2. 2019
5CTCFL
BORIS: a key regulator of cancer stemness.
Soltanian S, Dehghani H.
Cancer Cell Int 18:154. doi: 10.1186/s12935-018-0650-8. eCollection 2018. Review. 2018
6CTCF, CTCFL
Choice of binding sites for CTCFL compared to CTCF is driven by chromatin and by sequence preference.
Bergmaier P, Weth O, Dienstbach S, Boettger T, Galjart N, Mernberger M, Bartkuhn M, Renkawitz R.
Nucleic Acids Res 46(14):7097-7107. doi: 10.1093/nar/gky483. 2018
7CTCF, CTCFL
Discovering a binary CTCF code with a little help from BORIS.
Lobanenkov VV, Zentner GE.
Nucleus 9(1):33-41. doi: 10.1080/19491034.2017.1394536. Epub 2017 Dec 5. Review. 2018
8CTCFL
Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinoma.
He J, Huang Y, Liu Z, Zhao R, Liu Q, Wei L, Yu X, Li B, Qin Y.
Gene 629:29-34. doi: 10.1016/j.gene.2017.07.077. Epub 2017 Jul 29. 2017
9CTCFL
A polymorphic minisatellite region of BORIS regulates gene expression and its rare variants correlate with lung cancer susceptibility.
Yoon SL, Roh YG, Chu IS, Heo J, Kim SI, Chang H, Kang TH, Chung JW, Koh SS, Larionov V, Leem SH.
Exp Mol Med 48(7):e246. doi: 10.1038/emm.2016.50. 2016
10CTCFL
Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L, Losi L, Leyvraz S, Benhattar J.
PLoS One 10(7):e0132977. doi: 10.1371/journal.pone.0132977. eCollection 2015. 2015
11CTCFL, MAGEA1, SP1
Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein.
Schwarzenbach H, Eichelser C, Steinbach B, Tadewaldt J, Pantel K, Lobanenkov V, Loukinov D.
BMC Cancer 14:796. doi: 10.1186/1471-2407-14-796. 2014
12CTCFL, NOTCH3
The epigenetic factor BORIS/CTCFL regulates the NOTCH3 gene expression in cancer cells.
Zampieri M, Ciccarone F, Palermo R, Cialfi S, Passananti C, Chiaretti S, Nocchia D, Talora C, Screpanti I, Caiafa P.
Biochim Biophys Acta 1839(9):813-25. doi: 10.1016/j.bbagrm.2014.06.017. Epub 2014 Jun 28. 2014
13CTCFL
BORIS/CTCFL is an RNA-binding protein that associates with polysomes.
Ogunkolade BW, Jones TA, Aarum J, Szary J, Owen N, Ottaviani D, Mumin MA, Patel S, Pieri CA, Silver AR, Sheer D.
BMC Cell Biol 14:52. doi: 10.1186/1471-2121-14-52. 2013
14CTCF, CTCFL
The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells.
Tiffen JC, Bailey CG, Marshall AD, Metierre C, Feng Y, Wang Q, Watson SL, Holst J, Rasko JE.
Int J Cancer 133(7):1603-13. doi: 10.1002/ijc.28184. Epub 2013 May 2. 2013
15CTCFL
A cell cycle role for the epigenetic factor CTCF-L/BORIS.
Rosa-Garrido M, Ceballos L, Alonso-Lecue P, Abraira C, Delgado MD, Gandarillas A.
PLoS One 7(6):e39371. doi: 10.1371/journal.pone.0039371. Epub 2012 Jun 19. 2012
16CTCFL, PRSS50
Transcription factor BORIS (Brother of the Regulator of Imprinted Sites) directly induces expression of a cancer-testis antigen, TSP50, through regulated binding of BORIS to the promoter.
Kosaka-Suzuki N, Suzuki T, Pugacheva EM, Vostrov AA, Morse HC 3rd, Loukinov D, Lobanenkov V.
J Biol Chem 286(31):27378-88. Epub 2011 Jun 9. 2011
17CTCFL, TSHZ1
Genome-wide copy number profiling using a 100K SNP array reveals novel disease-related genes BORIS and TSHZ1 in juvenile angiofibroma.
Schick B, Wemmert S, Willnecker V, Dlugaiczyk J, Nicolai P, Siwiec H, Thiel CT, Rauch A, Wendler O.
Int J Oncol 39(5):1143-51. doi: 10.3892/ijo.2011.1166. Epub 2011 Aug 18. 2011
18CTCFL, MAGEA2, MAGEA3, MAGEA4
BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer.
Bhan S, Negi SS, Shao C, Glazer CA, Chuang A, Gaykalova DA, Sun W, Sidransky D, Ha PK, Califano JA.
Clin Cancer Res. Jul 1;17(13):4267-76. doi: 10.1158/1078-0432.CCR-11-0653. Epub 2011 May 10 2011
19CTCFL, GAL3ST1
Expression of a testis-specific form of Gal3st1 (CST), a gene essential for spermatogenesis, is regulated by the CTCF paralogous gene BORIS.
Suzuki T, Kosaka-Suzuki N, Pack S, Shin DM, Yoon J, Abdullaev Z, Pugacheva E, Morse HC 3rd, Loukinov D, Lobanenkov V.
Mol Cell Biol 30(10):2473-84. Epub 2010 Mar 15.PMID: 20231363 2010
20CTCFL
Molecular architecture of CTCFL.
Campbell AE, Martinez SR, Miranda JJ.
Biochem Biophys Res Commun 396(3):648-50. Epub 2010 May 8.PMID: 20438700 2010
21CTCFL
Expression of BORIS in melanoma: lack of association with MAGE-A1 activation.
Kholmanskikh O, Loriot A, Brasseur F, De Plaen E, De Smet C.
Int J Cancer 122(4):777-84. 2008
22CTCFL
BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours.
D'Arcy V, Pore N, Docquier F, Abdullaev ZK, Chernukhin I, Kita GX, Rai S, Smart M, Farrar D, Pack S, Lobanenkov V, Klenova E.
Br J Cancer 98(3):571-9. Epub 2008 Jan 15. Erratum in: Br J Cancer. 2008 Feb 12;98(3):676. PMID: 18195709 2008
23CTCFL
Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors.
Renaud S, Pugacheva EM, Delgado MD, Braunschweig R, Abdullaev Z, Loukinov D, Benhattar J, Lobanenkov V.
Nucleic Acids Res 35(21):7372-88. Epub 2007 Oct 25. 2007
24CTCFL
BORIS, a novel male germ-line-specific protein associated with epigeneticreprogramming events, shares the same 11-zinc-finger domain with CTCF, theinsulator protein involved in reading imprinting marks in the soma.
Loukinov DI, Pugacheva E, Vatolin S, Pack SD, Moon H, Chernukhin I, MannanP, Larsson E, Kanduri C, Vostrov AA, Cui H, Niemitz EL, Rasko JE, Docquier FM,Kistler M, Breen JJ, Zhuang Z, Quitschke WW, Renkawitz R, Klenova EM, FeinbergAP, Ohlsson R, Morse HC 3rd, Lobanenkov VV.
Proc Natl Acad Sci U S A 99(10):6806-11. 2002
25CTCFL
BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma.
Loukinov DI, Pugacheva E, Vatolin S, Pack SD, Moon H, Chernukhin I, Mannan P, Larsson E, Kanduri C, Vostrov AA, Cui H, Niemitz EL, Rasko JE, Docquier FM, Kistler M, Breen JJ, Zhuang Z, Quitschke WW, Renkawitz R, Klenova EM, Feinberg AP, Ohlsson R, Morse HC 3rd, Lobanenkov VV.
Proc Natl Acad Sci U S A 99(10):6806-11. 2002